The valencia programme for fertility preservation

  • María Sánchez
  • Edurne Novella-Maestre
  • José Teruel
  • Ester Ortiz
  • Antonio Pellicer
  • V. Mirabet
Research Articles



Fertility preservation needs have increased dramatically in recent years due to a rising cancer incidence and also a significant increase in survival rates.

Materials and methods

We report on 200 women participating in the Valencia Programme for Fertility Preservation, of whom 55% were breast cancer patients, 25% Hodgkin’s disease patients, and the remaining 20% suffered from other nonmalignant and malignant diseases. Mean age was 28.2 years (11–39). Before patients were submitted to oncological treatment, the right ovarian cortex was extracted by laparoscopy and cryopreserved. Once the patient was free of disease, the right ovarian cortex was thawed and implanted onto the left ovarian medulla (after extraction at the same surgical time of left ovarian cortex).


In 95% of cases, a piece ∼2 × 3 cm was obtained. The procedure did not cause any change in the cancer therapy schedule. Four implants had been performed (all of them in women who underwent chemotherapy prior to ovarian cortex extraction), from which two of the cases achieved ovarian function resumption, in one case a month after the implant and in the other 5.5 months after. The remaining two implanted cases were performed 5 and 6 months prior to the writing of this paper, respectively.


Ovarian tissue cryopreservation is a feasible option to preserve ovarian function and possibly fertility in adolescents and young women at risk of developing premature ovarian failure (POF) due to chemotherapy and/or radiotherapy.


Fertility preservation Ovarian tissue Cryopreservation Chemotherapy 


  1. 1.
    Jemal A, Clegg LX, Ward E et al (2004) Annual report to the nation on the status of cancer, 1975–2001, with a special feature regarding survival. Cancer 101:3–27PubMedCrossRefGoogle Scholar
  2. 2.
    Pizzo PA, Poplack DG (eds) (2006) Principles and practice of pediatric oncology. 5th edn. Lippincott Williams and Wilkins, PhiladelphiaGoogle Scholar
  3. 3.
    Viviani S, Santoro A, Ragni G et al (1985) Gonadal toxicity after combination chemotherapy for Hodgkin’s disease. Comparative results of MOPP vs ABVD. Eur J Cancer Clin Oncol 21:601–605PubMedCrossRefGoogle Scholar
  4. 4.
    Ghafoor A, Jemal A, Ward E et al (2003) Trends in breast cancer by race and ethnicity. CA Cancer J Clin 53:342–355PubMedCrossRefGoogle Scholar
  5. 5.
    Apperley JF, Reddy N (1995) Mechanism and management of treatment-related gonadal failure in recipients of high dose chemoradiotherapy. Blood Rev 9:93–116PubMedCrossRefGoogle Scholar
  6. 6.
    Meirow D, Nugent D (2001) The effects of radiotherapy and chemotherapy on female reproduction. Hum Reprod Update 7:535–543PubMedCrossRefGoogle Scholar
  7. 7.
    Lee SJ, Schover LR, Partridge AH Patrizio P et al (2006) American Society of Clinical Oncology Recommendations on Fertility Preservation in People Treated for Cancer. J Clin Oncol 24:2917–2931.PubMedCrossRefGoogle Scholar
  8. 8.
    Donnez J, Dolmans MM, Demylle D et al (2004) Livebirth after orthotopic transplantation of cryopreserved ovarian tissue. Lancet 364:1405–1410PubMedCrossRefGoogle Scholar
  9. 9.
    Demeestere I, Simon P, Emiliani S et al (2007) Fertility preservation: successful transplantation of cryopreserved ovarian tissue in a young patient previously treated for Hodgkin’s disease. Oncologist 12:1437–1442PubMedCrossRefGoogle Scholar
  10. 10.
    Meirow D, Levron J, Eldar-Geva T et al (2005) Pregnancy after transplantation of cryopreserved ovarian tissue in a patient with ovarian failure after chemotherapy. N Engl J Med 353:318–321PubMedCrossRefGoogle Scholar
  11. 11.
    Liu L, Wood GA, Morikawa L (2008) Restoration of fertility by orthotopic transplantation of frozen adult mouse ovaries. Hum Reprod 23:122–128.PubMedCrossRefGoogle Scholar
  12. 12.
    Kim SS, Yang HW, Kang HG et al (2004) Quantitative assessment of ischemic tissue damage in ovarian cortical tissue with or without antioxidant (ascorbic acid) treatment. Fertil Steril 82:679–685PubMedCrossRefGoogle Scholar
  13. 13.
    Liu J, Van der Elst J, Van der Broecke R, Dhont M (2002) Early massive follicle loss and apoptosis in heterotopically grafted newborn mouse ovaries. Hum Reprod 17:605–611PubMedCrossRefGoogle Scholar
  14. 14.
    Sánchez M, Alama P, Gadea B et al (2007) Fresh human orthotopic ovarian cortex transplantation: long-term results. Hum Reprod 22:786–791PubMedCrossRefGoogle Scholar
  15. 15.
    Oktay K, Karlikaya (2000). Ovarian function after transplantation of frozen, banked autologous ovarian tissue. N Engl J Med 342:1919PubMedCrossRefGoogle Scholar
  16. 16.
    Radford JA, Lieberman BA, Brison D et al (2001) Orthotopic reimplantation of cryopreserved ovarian cortical strips after high-dose chemotherapy for Hodgkin’s lymphoma. Lancet 357:1172–1175PubMedCrossRefGoogle Scholar
  17. 17.
    Schmidt KL, Andersen CY, Loft A et al (2005) Follow-up of ovarian function post-chemotherapy following ovarian cryopreservation and transplantation. Hum Reprod 20:3539–3546PubMedCrossRefGoogle Scholar
  18. 18.
    Donnez J, Dolmans MM, Demylle D et al (2006) Restoration of ovarian function after orthotopic (intraovarian and periovarian) transplantation of cryopreserved ovarian tissue in a woman treated by bone marrow transplantation for sickle cell anemia: case report. Hum Reprod 21:183–188PubMedCrossRefGoogle Scholar
  19. 19.
    Demeestere I, Simon P, Buxant F et al (2006) Ovarian function and spontaneous pregnancy after combined heterotopic and orthotopic cryopreserved ovarian tissue transplantation in a patient previously treated with bone marrow transplantation: case report. Hum Reprod 21:2010–2014.PubMedCrossRefGoogle Scholar
  20. 20.
    Thewes B, Meiser B, Taylor A et al (2005) Fertility-and menopause-related information needs of younger women with a diagnosis of early breast cancer. J Clin Oncol 23:5155–5165PubMedCrossRefGoogle Scholar
  21. 21.
    Oktay K, Hourwitz A, Sahin G et al (2006) Letrozole reduces estrogen and gonadotropin exposure in women with breast cancer undergoing ovarian stimulation before chemotherapy. J Clin Endocrinol Metab 91:3885–3890PubMedCrossRefGoogle Scholar

Copyright information

© Feseo 2008

Authors and Affiliations

  • María Sánchez
    • 1
    • 2
  • Edurne Novella-Maestre
    • 1
    • 4
  • José Teruel
    • 2
  • Ester Ortiz
    • 1
  • Antonio Pellicer
    • 1
    • 2
    • 4
  • V. Mirabet
    • 3
  1. 1.Hospital Universitario Dr. Peset IVI-ValenciaValenciaSpain
  2. 2.Instituto Valenciano de Infertilidad (IVI)ValenciaSpain
  3. 3.Centro de Transfusión de la Comunidad ValencianaValenciaSpain
  4. 4.Valencia UniversityValenciaSpain

Personalised recommendations